After gutting these adenoviruses and removing their pathogenic genes, researchers can insert a greater amount of therapeutic DNA than is allowed by AAV vectors. Lentiviruses, the most prominent example of which is HIV, have also been defused in the laboratory and converted into effective delivery vehicles.
